3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
23
Breast Neoplasms
18
Neoplasm Metastasis
2
Her-2 Negative Breast Cancer
1
HER2-negative Breast Cancer
1
Gastrointestinal Neoplasms
1
BRCA-Mutated Breast Carcinoma
1
Advanced Triple Negative Breast Cancer
1
Interventions
lenvatinib
1
camrelizumab
1
apatinib
1
Cyclophosphamide
1
Albumin-Bound Paclitaxel
1
ALT-803
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Triple Negative Breast Cancer
×
camrelizumab
×
Breast
×
Clear all
NCT06849492
2025-02-27
SHIFT-001
Fudan University
Phase 2
Not yet recruiting
120 enrolled